|
The following article on Phytoplenolin® was first published in 1998 Cosmetics and Toiletries Manufacture Worldwide. Phytoplenolin ®*
*Phytoplenolin (R) as used in this monograph is the same as Plantolin-Australia (R), registered by Koori marketing Pty, Ltd, and Bio-Botanica Inc Abstract The special extraction procedure and the mentioned biological activities of the extract are presently U.S.A. Patent Pending filed by the authors.
Introduction Results
and Discussion Analysis of the oil
was carried out by GC/MS under condition that allowed direct comparison
with reported data on reference terpenes (9). Both retention times and
mass spectral fragmentation were used in the identification of the individual
components of the oil. Table 1 shows
a list of all components and their relative percentage in the oil. For
all unidentified components the most significant mass spectral fragments
and retention times (in seconds) are provided. View Table 1 (large image file - 96k) The composition
is determined based on relative response in the chromatograms. The identification
of each component is based on direct comparison of the retention time
and mass spectral fragmentation with the data published by Adams (9) and
others (10-13). The mass spectral library fit (Wiley 139 Library) for
all identified components was more than 90%. It should be mentioned that
the GC column used in this study (Rtx®-5, 30m x 0.25 mm, 0.25um film thickness)
was similar to that reported by Adams (9). The data presented
in Table 1 showed that the oil is
composed of at least sixty-two distinct peaks. Forty-four compounds have
been unequivocally identified constituting more than 90% of the oil. cis-Dihydrocarveol
(23.89%) trans-sabinyl acetate (22.97%) and trans-Chrysanthenyl acetate
(13.50%) were the major constituents; myrtenol constituted 5.85%; thymol,
1.5%; isoamyl caproate, 1.23%; and isobutyl isopentanoic acid ester, 1.18%
(Table I). Phytoplenolin(R)
belongs to the Daisy Family (Asteraceae, Compositae). It is an aromatic
perennial herb about 30cm high, with quite woolly young shoots. Stem,
green, cylindrical, longitudinally striated with short internodes; leaves
(1-3cm) are green, simple sessile, alternate, oblong-ovate, margin, dentate,
apex acute, venation, pinnate reticulate, midrib conspicuous, prominent
on the lower side. Odor, characteristic,
aromatic, sternutatory; taste, aromatic, slightly bitter. The flower heads
are small (0.5-0.8cm in diam.) greenish and sessile. (Fig. 1,2 and 3) A unique holistically
balanced extract was prepared by a special procedure developed by Bio-Botanica.
A patent has been filed with the method of preparation of the special
extract done by Bio-Botanica, Inc. and the biological activities of this
extract. Fig. 4 shows the HPLC chromatogram of Bio-Botanica's product as compared to the products mentioned in the literature and prepared by either 95% ethanol (Fig. 5) or 50% ethanol (Fig. 6). Fig. 7 is a three dimensional HPLC chromatogram showing the most important sesquiterpene lactones peaks. View Fig. 4, Fig. 5 & Fig. 6 (image file - 53k) View Fig. 7 (image file - 33k) Before exploring the effectiveness of Bio-Botanica's extract when used topically it was deemed important to test in addition its safety on human skin. Therefore, the appropriate biological studies were performed by an independent laboratory*. The results were as follows: 1) The test used to prove the safety of Phytoplenolin(R) the Hen's Egg Test utilizing the chorioallantoic Membrane (HET-CAM) which proved to be more sensitive to liquid irritants than is the rabbit eye. Phytoplenolin(R) at 10% concentration had practically no occular irritation potential. 2) To test the anti-inflammatory activity two experiments were carried out: a) In the first experiment, the extract potential to decrease a chemically (lactic acid) induced erythemal response was evaluated. The test was performed on five carefully selected human subject and the percentage reduction in erythema (anti-inflammatory activity) was measured, when Phytoplenolin (R) compared almost equally with a standard 1% hyaluronic acid solution which is a well known moisturizing, soothing and emollient agent. Phytoplenolin(R) at 0.2% concentration alleviated inflammation as much as a 1.0% hyaluronic acid (5 times higher concentration) which is highly expensive. b) In the second anti-inflammatory experiment the potential of the extract to inhibit alpha-2-phospholipase enzyme was evaluated since it is known that activation of this enzyme causes inflammation. In this case an extract at a concentration of 0.025% sesquiterpene lactones showed to be as active as a preparation of Caribbean Gorgonians of the genus Pseudopterogorgia containing 0.06% pseudopterosins which possess a well proven and patented anti-inflammatory effect. (14) 3) In this clinical experiment we tried to explore the possible healing effect of the extract. Six human subjects were carefully selected in order to evaluate Dansyl chloride cell renewal properties. In this test a dye [Dansyl chloride, (5-methyl-amino-1-napthalene-sulphonyl chloride)] is applied to the skin leaving a dye stain which disappears proportionally with the characteristic power of the applied preparation to induce the formation of new cells which displace the dye colored cells. The preparation (0.2% sesquiterpene lactones) was compared to a standard 2% alpha-hydroxy-acid lotion (known to be a potent cell renewal agent). Phytoplenolin (R) gave a 50% reduction in the stain as compared to the untreated site of the skin after 11 days while the standard preparation gave only 38% reduction after the same period of time (see Table 2 & Fig. 8) this means that the 50% cell renewal response was attained more quickly by Plantolin(R) which was applied at a much lower concentration of 0.2% (alpha-hydroxy-acid preparation, 2.0%). View Table 2 (image file - 44k) View Fig. 8 (image file - 28k) In other words Phytoplenolin (R) is very effective as a cell renewal agent at comparatively very low concentration without the drawbacks of the drastic, mechanical, exfoliating and caustic effects of the alpha-hydroxy-acids. On the contrary the extract is anti-inflammatory as proven above while acting as a smooth cell renewing agent. It is, therefore, undoubtful - in our opinion - that consumers will turn to the use of Phytoplenolin for cell renewal in the near future. 4) The efficacy of Phytoplenolin (R) as a sunscreen product was tested on five carefully selected human subjects. The Sun Protection Factor (SPF) was determined taking a preparation of 8% Homosalate (SPF=4.0) as standard. Phytoplenolin (R) preparation gave an average SPF± SE = 1.68±0.08 viz even if the SPF of Phytoplenolin (R) is not too high it should protect against sunburn due to its potent anti-inflammatory property and will be very helpful if added to sunscreen products. In conclusion it is too good to believe that we have at hand a product with potent Anti-inflammatory, cell renewal (healing) agent with distinct sunscreen activity. If these effects, which were demonstrated by biological and clinical studies carried out by a reputable laboratory, are combined to the the effects cited in the literature as antihistaminic (4) antimutagenic (6) and antiviral(7) agent, it is easy to understand the effectiveness of Plantolin (R) preparations in Psoriasis and Herpes Simplex (15). Moreover, it will not be difficult to conceive that Phytoplenolin(R) will definitely cause a new Revolution in the cosmetic and Skin Care Industry. Experimental Plant Material: The flowering tops together with the leaves of Centipeda cunninghami, A. Br. & Ascher., Fam. Asteraceae were collected early in the morning of December 7, 1995, from the District of Kinglake, Victoria, Australia, from special plots grown to Industry Standards over a period of nine years. The plant was dried at room temperature on racks in the shade. It was identified by R. W. Taylor, Horticulturist, Government Researcher and T. V. Wunnik ND,DC. Fellow A.N.T.A. to whom the authors are indebted. A Voucher sample is kept at the herbarium of Bio-Botanica, Inc. at Hauppauge, New York. Preparation of the Volatile Oil, Quantitative Determination and Physical Constants: 100g of plant material were accurately weighed and steam distilled in a glass distillation apparatus for volatile oils lighter than water. The oil floating on the surface (which was minimal), together with the turbid distillate in the stem of the receiver were extrated with diethyl ether (3x25 ml) dried over anhydrous sodium sulphate and the ether evaporated spontaneously at about 28°C in a fuming cupboard. The oil obtained was measured and the percentage yield calculated. Refractive Index and Specific Gravity determinations were carried out at 20o C as described in U.S.P.XXIII. Reference
Standards Volatile
Oil Solution GC/MS Analysis For chromatographic separation a 0.25 mm x 30m, 0.25 um film thickness, RTX(R) -5 column (Restek Corporation) was used: injector temperature 220oC, oven temperature (programmed) 60-240 oC at 3°C/min, with a total run time 65 min, carrier gas He at a linear velocity of 32 cm/s. Injections of 1 ul were carried out in the split mode at a ratio of 1:20. Literature Cited 1. A. Campbell, Aust. J. Pharm., 54, 894 (1973-74) 2. H. W. Yu, C. W. Wright, Y. Cai, S. L. Yang, J. D. Phillipson, G. C. Kriby and D. C. Warhurst, Phytotherapy Res., 8(7), 436 (1994). 3. Herb-paint health promotion, Patent No. 87102584 (1987), CAS Registry/EC Number(s), 1490-04-6 4. J.B. Wu, Y.T. Chun, Y. Ebizuka and U.Sanwaka, Chem. Parm Bull., 39(12), 3272 (1991). 5. S. Iwakami, J. B. Wu, Y. Ebizuka, U. Sankawa, Checm. Pharm. Bull., 40(5), 1196 (1992) 6. H.Lee and J.Y. Lin, Mutat. Res., 204(2), 229(1988). 7. Y. C. Lin, T. I. Yang and C. S. Yang, Chin J. Microbiol., 6, 97 (1973) 8. J. T. Pinhey and I. ASouthwell, Aust. J. Chem. 24, 1313 (1971) 9. R. P. Adams, Identification of Essential Oils by Ion Trap Mass Spectrometry, Academic Press, New York (1989) 10. "Eight Peak Index of Mass Spectra", Vol. II, Mass Spectrometry Data Centre, Reading, U.K. (1974) 11. E. Stenhagen, S. Abrahamsson and F.W. McLafferty, "Registry of Mass Spectral Data:, Vol. 1 & 2, John Wiley & Sons, N.Y., London, Sydney, Toronto (1974) 12. Y, Massada, "Analysis of Essential Oils by Gas Chromatography and Mass Spectrometry" John Wiley & Sons, N.Y. (1976) 13. V.P. Papageorgiou, Planta Med., Suppl., pp29-33 (1980) 14. R.S. Jacobs and W.H. Fenical, U. S. Patent No. 4, 745, 104 (may 17, 1988) and No. 4, 849, 410 (july 18, 1989) 15. Y. W. Mirhom, personal communication (1996) |
|
Specification Sheet Product
Name: Product
Description:
|